vs

Side-by-side financial comparison of CME Group (CME) and JinkoSolar Holding Co., Ltd. (JKS). Click either name above to swap in a different company.

JinkoSolar Holding Co., Ltd. is the larger business by last-quarter revenue ($2.5B vs $1.9B, roughly 1.3× CME Group). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -23.1%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

JinkoSolar Holding Co., Ltd. is a solar module manufacturer headquartered in Shanghai, China, and listed on the New York Stock Exchange since 2010. Its subsidiary Jinko Solar Co., Ltd. was listed on the Shanghai Stock Exchange's Science and Technology Innovation Board in 2022.

CME vs JKS — Head-to-Head

Bigger by revenue
JKS
JKS
1.3× larger
JKS
$2.5B
$1.9B
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-23.1%
JKS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
JKS
JKS
Revenue
$1.9B
$2.5B
Net Profit
$1.2M
Gross Margin
0.3%
Operating Margin
0.1%
Net Margin
0.1%
Revenue YoY
14.5%
Net Profit YoY
20.7%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
JKS
JKS
Q2 26
$2.5B
Q1 26
$1.9B
Q4 25
$1.6B
Q3 25
$1.5B
Q2 25
$1.7B
$2.3B
Q1 25
$1.6B
$1.9B
Q4 24
$1.5B
Q3 24
$1.6B
$3.5B
Net Profit
CME
CME
JKS
JKS
Q2 26
Q1 26
$1.2M
Q4 25
$1.2B
Q3 25
$908.0M
Q2 25
$1.0B
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Gross Margin
CME
CME
JKS
JKS
Q2 26
0.3%
Q1 26
Q4 25
Q3 25
Q2 25
7.3%
Q1 25
Q4 24
Q3 24
15.7%
Operating Margin
CME
CME
JKS
JKS
Q2 26
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Net Margin
CME
CME
JKS
JKS
Q2 26
Q1 26
0.1%
Q4 25
71.7%
Q3 25
59.1%
Q2 25
60.6%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
EPS (diluted)
CME
CME
JKS
JKS
Q2 26
Q1 26
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
JKS
JKS
Cash + ST InvestmentsLiquidity on hand
$2.4B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
Total Assets
$202.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
JKS
JKS
Q2 26
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Total Debt
CME
CME
JKS
JKS
Q2 26
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Stockholders' Equity
CME
CME
JKS
JKS
Q2 26
Q1 26
Q4 25
$28.7B
Q3 25
$28.2B
Q2 25
$27.7B
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Total Assets
CME
CME
JKS
JKS
Q2 26
Q1 26
$202.0B
Q4 25
$198.4B
Q3 25
$187.1B
Q2 25
$179.9B
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons